SGX Pharmaceuticals, Inc. (SGXP)

[surf1944]

SGX Pharmaceuticals to Present at Three Upcoming Investor Conferences
Tuesday October 30, 5:18 pm ET

SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP - News) announced today that the company will be presenting at three upcoming investor conferences during which Mike Grey, president & chief executive officer of SGX Pharmaceuticals, will provide a corporate overview on the Company's oncology pipeline. The conference information is as follows:

-- BIOCOM Investor Conference Presentation: Thursday, November 1, 2007,
at 9:00 AM Pacific Daylight Time at the Marriott Del Mar in San Diego.

-- Rodman & Renshaw 9th Annual Healthcare Conference Presentation:
Wednesday, November 7, 2007 at 8:50 AM Eastern Standard Time at the New
York Palace Hotel, New York City.

-- CIBC 18th Annual Healthcare Conference Presentation: Wednesday,
November 7, 2007 at 10:55 AM Eastern Standard Time at the Waldorf-
Astoria Hotel in New York City.


A live webcast of the Rodman & Renshaw presentation will be available under the investor relations section of the Company's website at http://www.sgxpharma.com. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About SGX Pharmaceuticals

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis and MET tyrosine kinase inhibitors, including SGX523, and potent JAK2 inhibitors. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.